| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Muscle, Skeletal | 25 | 2024 | 472 | 4.970 |
Why?
|
| Muscular Dystrophy, Duchenne | 10 | 2024 | 35 | 2.960 |
Why?
|
| Annexin A6 | 6 | 2022 | 10 | 2.150 |
Why?
|
| Muscular Dystrophies | 7 | 2024 | 55 | 2.030 |
Why?
|
| Muscle Proteins | 8 | 2021 | 132 | 2.020 |
Why?
|
| Cell Membrane | 9 | 2021 | 684 | 1.920 |
Why?
|
| Membrane Proteins | 11 | 2021 | 1239 | 1.890 |
Why?
|
| Muscular Dystrophy, Animal | 8 | 2019 | 21 | 1.770 |
Why?
|
| Muscle Fibers, Skeletal | 6 | 2019 | 51 | 1.710 |
Why?
|
| Immunoglobulin G | 6 | 2023 | 457 | 1.680 |
Why?
|
| Muscular Dystrophies, Limb-Girdle | 6 | 2024 | 15 | 1.400 |
Why?
|
| Dysferlin | 6 | 2024 | 14 | 1.320 |
Why?
|
| Calcium | 4 | 2022 | 1182 | 1.150 |
Why?
|
| Mice, Inbred mdx | 5 | 2024 | 13 | 1.120 |
Why?
|
| Muscle Development | 6 | 2019 | 42 | 1.090 |
Why?
|
| Dried Blood Spot Testing | 3 | 2021 | 10 | 1.070 |
Why?
|
| Vesicular Transport Proteins | 3 | 2015 | 66 | 1.000 |
Why?
|
| Muscles | 3 | 2024 | 188 | 0.950 |
Why?
|
| Disease Models, Animal | 8 | 2024 | 2443 | 0.940 |
Why?
|
| Vaccines, Synthetic | 2 | 2021 | 58 | 0.920 |
Why?
|
| Mice | 28 | 2025 | 12103 | 0.860 |
Why?
|
| Myoblasts | 7 | 2024 | 32 | 0.790 |
Why?
|
| Sarcolemma | 10 | 2019 | 32 | 0.790 |
Why?
|
| Animals | 37 | 2025 | 27974 | 0.790 |
Why?
|
| Sarcoglycans | 7 | 2024 | 14 | 0.780 |
Why?
|
| Membrane Fusion | 3 | 2021 | 38 | 0.770 |
Why?
|
| Neuromuscular Diseases | 1 | 2021 | 29 | 0.750 |
Why?
|
| Myocytes, Cardiac | 8 | 2024 | 317 | 0.750 |
Why?
|
| Excitation Contraction Coupling | 1 | 2021 | 8 | 0.750 |
Why?
|
| Biomarkers | 3 | 2024 | 1846 | 0.740 |
Why?
|
| Family Characteristics | 2 | 2022 | 49 | 0.740 |
Why?
|
| Serologic Tests | 2 | 2021 | 43 | 0.730 |
Why?
|
| Annexins | 2 | 2022 | 6 | 0.730 |
Why?
|
| Pandemics | 5 | 2023 | 810 | 0.680 |
Why?
|
| Induced Pluripotent Stem Cells | 5 | 2024 | 131 | 0.670 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2010 | 115 | 0.650 |
Why?
|
| Gene Editing | 1 | 2019 | 49 | 0.640 |
Why?
|
| Exons | 3 | 2019 | 453 | 0.640 |
Why?
|
| Spike Glycoprotein, Coronavirus | 5 | 2022 | 44 | 0.630 |
Why?
|
| Antibodies, Viral | 6 | 2022 | 300 | 0.600 |
Why?
|
| Health Personnel | 1 | 2020 | 222 | 0.580 |
Why?
|
| Muscle Cells | 1 | 2017 | 18 | 0.560 |
Why?
|
| Betacoronavirus | 1 | 2020 | 270 | 0.550 |
Why?
|
| Prednisone | 4 | 2024 | 254 | 0.540 |
Why?
|
| Protein Transport | 8 | 2016 | 430 | 0.540 |
Why?
|
| Health | 1 | 2015 | 29 | 0.490 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 329 | 0.480 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 314 | 0.480 |
Why?
|
| Disease | 1 | 2015 | 91 | 0.470 |
Why?
|
| Neutralization Tests | 4 | 2022 | 70 | 0.470 |
Why?
|
| Glucocorticoids | 5 | 2024 | 366 | 0.460 |
Why?
|
| Muscular Diseases | 3 | 2023 | 65 | 0.450 |
Why?
|
| Dynamin II | 1 | 2014 | 15 | 0.450 |
Why?
|
| Myopathies, Structural, Congenital | 1 | 2014 | 11 | 0.450 |
Why?
|
| Quadriceps Muscle | 1 | 2014 | 5 | 0.450 |
Why?
|
| Proteostasis | 2 | 2024 | 12 | 0.440 |
Why?
|
| Glycerol | 1 | 2013 | 35 | 0.430 |
Why?
|
| Male | 20 | 2025 | 43858 | 0.430 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2024 | 3499 | 0.420 |
Why?
|
| Actins | 1 | 2016 | 470 | 0.410 |
Why?
|
| Antibodies, Neutralizing | 3 | 2022 | 124 | 0.400 |
Why?
|
| Fibrosis | 4 | 2023 | 239 | 0.390 |
Why?
|
| Mice, Knockout | 6 | 2024 | 2085 | 0.390 |
Why?
|
| Gene Expression | 3 | 2019 | 1312 | 0.380 |
Why?
|
| Antibody Formation | 2 | 2021 | 170 | 0.360 |
Why?
|
| Seroepidemiologic Studies | 2 | 2021 | 55 | 0.360 |
Why?
|
| RNA, Messenger | 3 | 2019 | 2037 | 0.350 |
Why?
|
| Mice, 129 Strain | 3 | 2021 | 57 | 0.350 |
Why?
|
| NFATC Transcription Factors | 1 | 2010 | 50 | 0.340 |
Why?
|
| Mice, Inbred C57BL | 7 | 2025 | 3356 | 0.340 |
Why?
|
| Latent TGF-beta Binding Proteins | 2 | 2021 | 4 | 0.330 |
Why?
|
| DNA | 1 | 2015 | 1307 | 0.330 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2009 | 45 | 0.330 |
Why?
|
| Wound Healing | 4 | 2016 | 368 | 0.330 |
Why?
|
| Female | 16 | 2025 | 47822 | 0.320 |
Why?
|
| Humans | 29 | 2024 | 92175 | 0.300 |
Why?
|
| Extracellular Matrix | 3 | 2024 | 249 | 0.290 |
Why?
|
| Young Adult | 5 | 2024 | 6615 | 0.270 |
Why?
|
| Carrier Proteins | 3 | 2021 | 680 | 0.270 |
Why?
|
| Vaccination | 3 | 2023 | 284 | 0.240 |
Why?
|
| Myosin Type V | 1 | 2025 | 13 | 0.240 |
Why?
|
| Cells, Cultured | 6 | 2018 | 2899 | 0.240 |
Why?
|
| Regeneration | 3 | 2017 | 158 | 0.240 |
Why?
|
| Ataxia | 1 | 2025 | 43 | 0.230 |
Why?
|
| Myosin Heavy Chains | 1 | 2025 | 91 | 0.230 |
Why?
|
| Immunoblotting | 2 | 2016 | 276 | 0.230 |
Why?
|
| Filamins | 1 | 2024 | 22 | 0.230 |
Why?
|
| Middle Aged | 7 | 2024 | 27001 | 0.230 |
Why?
|
| Adult | 7 | 2024 | 27494 | 0.220 |
Why?
|
| Cardiomyopathies | 2 | 2024 | 272 | 0.220 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2024 | 45 | 0.220 |
Why?
|
| Myocarditis | 1 | 2024 | 55 | 0.210 |
Why?
|
| Mice, Inbred DBA | 6 | 2024 | 148 | 0.210 |
Why?
|
| Mice, Mutant Strains | 2 | 2016 | 231 | 0.200 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2015 | 318 | 0.200 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2015 | 293 | 0.200 |
Why?
|
| Tissue Engineering | 1 | 2024 | 200 | 0.200 |
Why?
|
| Mice, Transgenic | 4 | 2022 | 1589 | 0.200 |
Why?
|
| Calcium-Binding Proteins | 2 | 2021 | 119 | 0.190 |
Why?
|
| Immunologic Tests | 1 | 2021 | 6 | 0.190 |
Why?
|
| Monocytes | 1 | 2023 | 223 | 0.190 |
Why?
|
| Nerve Tissue Proteins | 2 | 2015 | 507 | 0.190 |
Why?
|
| Drug Interactions | 1 | 2021 | 244 | 0.180 |
Why?
|
| Extracellular Vesicles | 1 | 2022 | 43 | 0.180 |
Why?
|
| Mitochondria | 1 | 2025 | 598 | 0.180 |
Why?
|
| Heart Diseases | 1 | 2023 | 308 | 0.180 |
Why?
|
| Steroids | 1 | 2021 | 173 | 0.170 |
Why?
|
| Cell Differentiation | 2 | 2024 | 1590 | 0.170 |
Why?
|
| Genes, Modifier | 2 | 2017 | 5 | 0.170 |
Why?
|
| Immunity, Innate | 1 | 2024 | 438 | 0.170 |
Why?
|
| Muscle Contraction | 1 | 2021 | 287 | 0.170 |
Why?
|
| Cell Movement | 1 | 2024 | 797 | 0.170 |
Why?
|
| Chicago | 2 | 2021 | 1468 | 0.160 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 373 | 0.160 |
Why?
|
| Lysosomes | 2 | 2010 | 117 | 0.160 |
Why?
|
| Mutation | 4 | 2025 | 4199 | 0.160 |
Why?
|
| Myotonic Dystrophy | 1 | 2019 | 7 | 0.160 |
Why?
|
| MyoD Protein | 1 | 2019 | 16 | 0.160 |
Why?
|
| Transforming Growth Factor beta | 1 | 2021 | 328 | 0.160 |
Why?
|
| Dual Specificity Phosphatase 6 | 1 | 2019 | 1 | 0.160 |
Why?
|
| Point Mutation | 1 | 2019 | 245 | 0.150 |
Why?
|
| Signal Transduction | 1 | 2009 | 3508 | 0.150 |
Why?
|
| Sarcoglycanopathies | 1 | 2018 | 2 | 0.150 |
Why?
|
| Severity of Illness Index | 1 | 2024 | 1916 | 0.150 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2019 | 122 | 0.150 |
Why?
|
| Morpholinos | 1 | 2018 | 13 | 0.150 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2024 | 1266 | 0.150 |
Why?
|
| Dystrophin | 4 | 2024 | 22 | 0.150 |
Why?
|
| Adolescent | 2 | 2021 | 9493 | 0.140 |
Why?
|
| Phenotype | 1 | 2024 | 2497 | 0.140 |
Why?
|
| Osteopontin | 1 | 2017 | 47 | 0.140 |
Why?
|
| Protein Binding | 4 | 2022 | 1512 | 0.140 |
Why?
|
| Recombinant Proteins | 1 | 2019 | 1016 | 0.140 |
Why?
|
| Phospholipids | 1 | 2017 | 112 | 0.130 |
Why?
|
| Genetic Therapy | 2 | 2018 | 377 | 0.130 |
Why?
|
| Sensitivity and Specificity | 1 | 2021 | 2006 | 0.130 |
Why?
|
| Microscopy, Fluorescence | 2 | 2018 | 441 | 0.130 |
Why?
|
| Exosomes | 1 | 2017 | 57 | 0.130 |
Why?
|
| Cell Communication | 1 | 2017 | 205 | 0.130 |
Why?
|
| Dystrophin-Associated Protein Complex | 1 | 2015 | 3 | 0.130 |
Why?
|
| Electroporation | 1 | 2015 | 54 | 0.120 |
Why?
|
| Base Sequence | 1 | 2019 | 2317 | 0.120 |
Why?
|
| Transcription Factors | 1 | 2024 | 1684 | 0.120 |
Why?
|
| Creatine Kinase | 1 | 2015 | 53 | 0.120 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2015 | 67 | 0.120 |
Why?
|
| Luminescent Proteins | 1 | 2015 | 142 | 0.120 |
Why?
|
| Plasmids | 1 | 2015 | 288 | 0.120 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 283 | 0.120 |
Why?
|
| Intracellular Space | 2 | 2014 | 38 | 0.120 |
Why?
|
| Protein Engineering | 1 | 2015 | 146 | 0.110 |
Why?
|
| Heterozygote | 1 | 2015 | 379 | 0.110 |
Why?
|
| Cell Adhesion | 1 | 2015 | 431 | 0.110 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2024 | 2388 | 0.110 |
Why?
|
| Cell Line | 4 | 2024 | 2504 | 0.110 |
Why?
|
| Caveolin 3 | 1 | 2014 | 4 | 0.110 |
Why?
|
| Cohort Studies | 1 | 2021 | 2972 | 0.110 |
Why?
|
| Fluorescent Dyes | 1 | 2015 | 260 | 0.110 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 923 | 0.110 |
Why?
|
| HIV Infections | 1 | 2023 | 893 | 0.110 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2013 | 137 | 0.110 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2015 | 388 | 0.110 |
Why?
|
| Aged | 2 | 2021 | 19915 | 0.110 |
Why?
|
| Cell Survival | 1 | 2015 | 1008 | 0.100 |
Why?
|
| Endosomes | 2 | 2010 | 82 | 0.100 |
Why?
|
| Cytoskeleton | 1 | 2014 | 202 | 0.100 |
Why?
|
| MicroRNAs | 1 | 2017 | 573 | 0.100 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2010 | 6 | 0.090 |
Why?
|
| Gene Expression Regulation | 3 | 2019 | 2002 | 0.090 |
Why?
|
| Cardiotoxins | 1 | 2010 | 3 | 0.090 |
Why?
|
| Lysosomal-Associated Membrane Protein 2 | 1 | 2009 | 4 | 0.080 |
Why?
|
| Myoblasts, Skeletal | 1 | 2009 | 3 | 0.080 |
Why?
|
| Myofibrils | 1 | 2009 | 22 | 0.080 |
Why?
|
| Calcium Signaling | 1 | 2010 | 140 | 0.080 |
Why?
|
| Models, Animal | 1 | 2010 | 282 | 0.080 |
Why?
|
| Models, Biological | 1 | 2015 | 1784 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 2445 | 0.070 |
Why?
|
| Endocytosis | 1 | 2008 | 185 | 0.070 |
Why?
|
| RNA Splicing | 2 | 2019 | 157 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 968 | 0.070 |
Why?
|
| Lamin Type A | 1 | 2006 | 26 | 0.070 |
Why?
|
| HEK293 Cells | 2 | 2022 | 666 | 0.070 |
Why?
|
| Annexin A2 | 1 | 2024 | 2 | 0.060 |
Why?
|
| Decorin | 1 | 2024 | 6 | 0.060 |
Why?
|
| Electrophysiological Phenomena | 1 | 2024 | 51 | 0.060 |
Why?
|
| Cell Nucleus | 1 | 2006 | 611 | 0.060 |
Why?
|
| Blood Proteins | 1 | 2024 | 149 | 0.060 |
Why?
|
| Bortezomib | 1 | 2024 | 81 | 0.060 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2024 | 138 | 0.050 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2024 | 201 | 0.050 |
Why?
|
| Quantitative Trait Loci | 2 | 2019 | 623 | 0.050 |
Why?
|
| Nuclear Proteins | 1 | 2006 | 734 | 0.050 |
Why?
|
| A549 Cells | 1 | 2022 | 47 | 0.050 |
Why?
|
| Stress, Physiological | 1 | 2024 | 245 | 0.050 |
Why?
|
| Vero Cells | 1 | 2022 | 103 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2024 | 899 | 0.050 |
Why?
|
| Proteomics | 1 | 2023 | 246 | 0.050 |
Why?
|
| Antibodies, Blocking | 1 | 2021 | 22 | 0.050 |
Why?
|
| Heart | 1 | 2024 | 583 | 0.050 |
Why?
|
| Immunoassay | 1 | 2021 | 93 | 0.050 |
Why?
|
| HeLa Cells | 1 | 2022 | 514 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 2 | 2015 | 741 | 0.040 |
Why?
|
| Anacardic Acids | 1 | 2019 | 1 | 0.040 |
Why?
|
| Pulse Therapy, Drug | 1 | 2019 | 2 | 0.040 |
Why?
|
| MEF2 Transcription Factors | 1 | 2019 | 10 | 0.040 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2023 | 332 | 0.040 |
Why?
|
| Genetic Variation | 2 | 2019 | 1392 | 0.040 |
Why?
|
| Histone Acetyltransferases | 1 | 2019 | 44 | 0.040 |
Why?
|
| Residence Characteristics | 1 | 2021 | 204 | 0.040 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2019 | 102 | 0.040 |
Why?
|
| Metabolomics | 1 | 2019 | 95 | 0.040 |
Why?
|
| Disease Progression | 1 | 2023 | 1503 | 0.040 |
Why?
|
| Epigenomics | 1 | 2019 | 103 | 0.040 |
Why?
|
| Reading Frames | 1 | 2018 | 6 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2022 | 1509 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2018 | 80 | 0.040 |
Why?
|
| Cellular Reprogramming | 1 | 2018 | 45 | 0.040 |
Why?
|
| Annexin A1 | 1 | 2017 | 5 | 0.040 |
Why?
|
| Urine | 1 | 2018 | 93 | 0.040 |
Why?
|
| Transduction, Genetic | 1 | 2018 | 161 | 0.040 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2017 | 46 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2019 | 807 | 0.040 |
Why?
|
| Mutation, Missense | 1 | 2019 | 284 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2017 | 108 | 0.030 |
Why?
|
| Muscular Atrophy | 1 | 2017 | 46 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2019 | 283 | 0.030 |
Why?
|
| Neurons | 1 | 2025 | 1594 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2017 | 298 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2017 | 315 | 0.030 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2017 | 141 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2019 | 1076 | 0.030 |
Why?
|
| Codon, Nonsense | 1 | 2015 | 45 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2017 | 868 | 0.030 |
Why?
|
| Diaphragm | 1 | 2015 | 52 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 538 | 0.030 |
Why?
|
| Protein Interaction Mapping | 1 | 2015 | 81 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 2790 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2018 | 767 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2015 | 210 | 0.030 |
Why?
|
| Abdominal Muscles | 1 | 2014 | 20 | 0.030 |
Why?
|
| Membranes | 1 | 2014 | 37 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 1773 | 0.030 |
Why?
|
| Chromosomes, Mammalian | 1 | 2014 | 37 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2015 | 559 | 0.030 |
Why?
|
| Organ Size | 1 | 2014 | 375 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2014 | 207 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2014 | 214 | 0.020 |
Why?
|
| Time Factors | 1 | 2021 | 5426 | 0.020 |
Why?
|
| Myocardium | 1 | 2015 | 585 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 2015 | 618 | 0.020 |
Why?
|
| Drosophila Proteins | 1 | 2015 | 513 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2010 | 560 | 0.020 |
Why?
|
| Heart Ventricles | 1 | 2014 | 795 | 0.020 |
Why?
|
| Transferrin | 1 | 2008 | 21 | 0.020 |
Why?
|
| Cell Fusion | 1 | 2008 | 39 | 0.020 |
Why?
|
| Child | 1 | 2019 | 7323 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2008 | 211 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2008 | 358 | 0.020 |
Why?
|
| Nuclear Envelope | 1 | 2006 | 39 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2006 | 97 | 0.020 |
Why?
|
| Hydroxyproline | 1 | 2005 | 11 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2008 | 2074 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2008 | 1336 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2008 | 3017 | 0.010 |
Why?
|
| Motor Activity | 1 | 2005 | 330 | 0.010 |
Why?
|